Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Oral Cavity & Pharynx (Late Stage^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank ascending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 7.4 (7.3, 7.4) N/A 28,787 62.4
Arizona 6 *** 5.2 (5.0, 5.4) 50 (46, 50) 448 57.9
Wyoming 6 *** 5.2 (4.5, 6.1) 49 (42, 50) 37 51.8
New Mexico 3 *** 5.4 (5.0, 5.8) 48 (45, 50) 139 60.3
Nevada 6 *** 5.4 (5.1, 5.9) 47 (45, 50) 151 50.8
Utah 3 *** 5.8 (5.4, 6.2) 46 (43, 50) 157 58.5
California 3 *** 6.4 (6.3, 6.5) 45 (38, 45) 2,806 63.2
Texas 6 *** 6.4 (6.3, 6.5) 44 (38, 45) 1,860 58.1
Alaska 6 *** 6.5 (5.7, 7.4) 43 (19, 49) 53 63.2
District of Columbia 6 *** 6.5 (5.7, 7.4) 42 (16, 49) 45 62.1
North Dakota 6 *** 6.6 (5.8, 7.4) 41 (18, 48) 57 53.8
Colorado 6 *** 6.6 (6.3, 6.9) 40 (32, 45) 417 62.1
Minnesota 6 *** 6.6 (6.3, 6.9) 39 (32, 45) 447 54.8
Idaho 3 *** 6.6 (6.1, 7.2) 38 (26, 46) 133 56.4
Alabama 6 *** 6.8 (6.5, 7.1) 37 (27, 44) 417 53.4
Virginia 6 *** 6.9 (6.7, 7.2) 36 (27, 41) 706 62.2
New Jersey 3 *** 7.0 (6.7, 7.2) 35 (26, 41) 779 62.5
South Dakota 6 *** 7.0 (6.3, 7.8) 34 (12, 46) 73 56.0
Maryland 6 *** 7.0 (6.7, 7.3) 33 (24, 41) 515 63.6
New York 3 *** 7.0 (6.9, 7.2) 32 (27, 39) 1,696 62.8
Oklahoma 6 *** 7.1 (6.7, 7.4) 31 (22, 42) 325 56.6
Kansas 6 *** 7.1 (6.7, 7.6) 30 (19, 42) 245 60.3
Washington 5 *** 7.2 (7.0, 7.5) 29 (21, 37) 634 59.3
Rhode Island 6 *** 7.3 (6.7, 8.0) 28 (9, 44) 102 65.6
Montana 6 *** 7.4 (6.7, 8.1) 27 (8, 44) 101 61.7
Nebraska 6 *** 7.4 (6.9, 7.9) 26 (11, 40) 165 58.5
Connecticut 3 *** 7.5 (7.1, 7.8) 25 (13, 36) 351 61.7
New Hampshire 6 *** 7.5 (7.0, 8.1) 24 (8, 40) 141 64.6
Oregon 6 *** 7.6 (7.3, 8.0) 23 (12, 32) 397 63.5
Michigan 5 *** 7.6 (7.4, 7.9) 22 (14, 29) 973 64.0
Delaware 6 *** 7.6 (7.0, 8.4) 21 (4, 41) 96 62.0
Iowa 3 *** 7.7 (7.3, 8.1) 20 (9, 31) 300 57.0
Wisconsin 6 *** 7.8 (7.5, 8.1) 19 (11, 28) 580 63.9
Hawaii 3 *** 7.8 (7.2, 8.4) 18 (4, 37) 138 58.8
Illinois 6 *** 7.8 (7.6, 8.0) 17 (12, 26) 1,192 64.4
Pennsylvania 6 *** 7.9 (7.7, 8.1) 16 (11, 24) 1,325 64.5
South Carolina 6 *** 7.9 (7.6, 8.2) 15 (8, 27) 504 64.3
Ohio 6 *** 8.0 (7.8, 8.2) 14 (8, 22) 1,185 66.2
North Carolina 6 *** 8.1 (7.9, 8.4) 13 (6, 20) 1,014 65.6
Indiana 6 *** 8.1 (7.9, 8.4) 12 (5, 21) 647 64.3
Mississippi 6 *** 8.3 (7.8, 8.7) 11 (2, 22) 299 64.0
Louisiana 3 *** 8.3 (8.0, 8.7) 10 (2, 19) 461 64.0
Tennessee 6 *** 8.4 (8.1, 8.7) 9 (3, 16) 693 64.5
Vermont 6 *** 8.4 (7.5, 9.4) 8 (1, 31) 73 69.8
Missouri 6 *** 8.4 (8.1, 8.7) 7 (2, 15) 644 66.6
Florida 6 *** 8.5 (8.4, 8.7) 6 (2, 11) 2,416 61.6
Georgia 3 *** 8.6 (8.3, 8.8) 5 (2, 12) 993 67.7
Maine 6 *** 8.6 (8.0, 9.2) 4 (1, 21) 165 63.2
Arkansas 6 *** 8.7 (8.3, 9.2) 3 (1, 13) 322 62.5
Kentucky 3 *** 9.0 (8.6, 9.3) 2 (1, 8) 497 64.9
West Virginia 6 *** 9.7 (9.1, 10.3) 1 (1, 3) 241 68.6
Massachusetts 3 ***
data not available
N/A
data not available
data not available
Puerto Rico 6 *** 3.8 (3.6, 4.1) N/A 173 39.6
Notes:
Created by statecancerprofiles.cancer.gov on 12/03/2021 5:30 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Coding is generally based on Surveillance, Epidemiology, and End Results (SEER) summary stage but may include other staging variables if necessary.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
3 Source: SEER November 2020 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2020 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top